Related Experiment Video
Updated: Oct 13, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Kidney injury molecule-1 as a predicting factor for inflamed kidney, diabetic and diabetic nephropathy Egyptian
Samia A Ahmed1, Manal A Hamed1
1Therapeutic Chemistry Department, National Research Centre, 33 El-Bohouth St., ID: 60014618 Dokki Cairo, Egypt.
Background:
Kidney injury molecule-1 (KIM-1), a recently discovered transmembrane protein, is expressed in dedifferentiated proximal renal tubular epithelial cells in damaged regions. Kidney injury early detection in diabetic patients has great importance for therapy and prognosis. Therefore, the aim of the present study is to predict, validate and evaluate the presence of KIM-1 in kidney inflammation, dialectic and diabetic nephropathy diseases.
Methods:
Sixty males and females subjects (30-52 years) were selected for this study. They were subdivided into three main groups; kidney injury, diabetic and diabetic nephropathy patients. The work was extended to evaluate KIM-1 after treatment of each disease.
Results:
The results revealed significant elevation of KIM-1 in the diseased groups and a noticeable reduction after treatment. Diabetic nephropathy recorded the highest KIM-1 level than the AKI state or the diabetic patients. We noticed an association between KIM-1 and sex and a positive correlation (p < 0.0001) with the disease severity.
Conclusions:
In conclusion, urinary KIM-1 has been reported to be a noninvasive, rapid, sensitive, and reproducible biomarker to detect early kidney injury. We speculate that KIM-1 is expected to be a therapeutic target for kidney injury.
Insights
Kidney injury molecule-1 (KIM-1) is elevated in kidney disease and diabetic nephropathy, decreasing after treatment. This biomarker shows potential for early kidney injury detection and as a therapeutic target.
Area of Science:
- Nephrology
- Biomarker Discovery
- Molecular Biology
Background:
- Kidney injury molecule-1 (KIM-1) is a transmembrane protein found in damaged kidney cells.
- Early detection of kidney injury in diabetic patients is crucial for treatment and prognosis.
- KIM-1's role in kidney inflammation and diabetic nephropathy requires further investigation.
Purpose of the Study:
- To predict, validate, and evaluate KIM-1 presence in kidney inflammation, diabetes, and diabetic nephropathy.
- To assess KIM-1 levels before and after treatment for these kidney conditions.
- To explore the correlation of KIM-1 with disease severity and patient demographics.
Main Methods:
- Study included 60 subjects (30-52 years) divided into kidney injury, diabetic, and diabetic nephropathy groups.
- KIM-1 levels were measured in all groups.
- KIM-1 was evaluated after treatment for each respective disease.
Main Results:
- Significant elevation of KIM-1 was observed in diseased groups, with a noticeable reduction post-treatment.
- Diabetic nephropathy exhibited the highest KIM-1 levels compared to acute kidney injury (AKI) or diabetic patients.
- KIM-1 showed an association with sex and a strong positive correlation with disease severity (p < 0.0001).
Conclusions:
- Urinary KIM-1 serves as a noninvasive, rapid, sensitive, and reproducible biomarker for early kidney injury detection.
- KIM-1 is a promising biomarker for monitoring kidney disease progression and treatment response.
- KIM-1 is anticipated to be a potential therapeutic target for kidney injury.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy
